Investment firm Kahn Brothers (Trades, Portfolio) was founded in 1978 by Irving Kahn, Thomas Graham Kahn and Alan Kahn. During the third quarter, the firm traded the following stocks:
The firm reduced its Straight Path Communications Inc. (STRP, Financial) holding by 67.57%, impacting the portfolio by -3.2%.
The telecommunication company has a market cap of $2.3 billion and an enterprise value of $2.3 billion.
GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on capital (ROC) of -15,982.90% and return on assets (ROA) of -328.67% are underperforming 100% of companies in the Global Telecom Services industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.76 is above the industry median of 0.37.
The company's largest shareholder among the gurus is Kahn Brothers with 0.44% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.27%, Paul Tudor Jones (Trades, Portfolio) with 0.2%, Mario Gabelli (Trades, Portfolio) with 0.09% and Murray Stahl (Trades, Portfolio) with 0.02%.
The New York Times Co. (NYT, Financial) position was reduced by 9.40%, impacting the portfolio by -0.87%.
The publishing company has a market cap of $2.79 billion and an enterprise value of $2.46 billion.
GuruFocus gives the company a profitability and growth rating of 5 out of 10. The return on equity (ROE) of 11.39% and ROA of 4.41% are outperforming 54% of companies in the Global Publishing industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.33 is above the industry median of 1.58.
The firm is the company's largest guru shareholder with 2.17% of outstanding shares, followed by Simons with 1.25%, Barrow, Hanley, Mewhinney & Strauss with 0.29% and Chuck Royce (Trades, Portfolio) with 0.19%.
The Hologic Inc. (HOLX, Financial) position was trimmed 8.46%. The transaction had an impact of -0.47% on the portfolio.
The diagnostic products manufacturer has a market cap of $11.09 billion and an enterprise value of $13.75 billion.
GuruFocus gives the company a profitability and growth rating of 6 out of 10. The ROE of 29.47% and ROA of 9.57% are outperforming 79% of companies in the Global Medical Instruments and Supplies industry. Financial strength has a rating of 5 out of 10. The cash-debt ratio of 0.16 is below the industry median of 1.69.
The Vanguard Health Care Fund (Trades, Portfolio) is the company's largest shareholder among the gurus with 1.25% of outstanding shares, followed by Simons with 0.44% and Jerome Dodson (Trades, Portfolio) with 0.26%.
The firm reduced its holding of Seaboard Corp. (SEB, Financial) by 4.69%. The trade had an impact of -0.24% on the portfolio.
The agribusiness and transportation company has a market cap of $5.13 billion and an enterprise value of $4.36 billion.
GuruFocus gives the company a profitability and growth rating of 5 out of 10. The ROE of 10.12% and ROA of 6.80% are outperforming 78% of companies in the Global Conglomerates industry. Financial strength has a rating of 7 out of 10. The cash-debt ratio of 2.23 is below the industry median of 4.54.
Another notable guru shareholder is Simons with 0.45% of outstanding shares, followed by Jones with 0.02% and Stahl with 0.01%.
The firm curbed its Citigroup Inc. (C, Financial) holding by 2.13%. The trade had an impact of -0.22% on the portfolio.
The bank has a market cap of $191.27 billion and an enterprise value of $296.22 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. The ROE of 6.24% and ROA of 0.85% are underperforming 69% of companies in the Global Banks – Global industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.69 is below the industry median of 2.05.
With 0.62% of outstanding shares, Barrow, Hanley, Mewhinney & Strauss is the company's largest guru shareholder, followed by Hotchkis & Wiley with 0.55%, First Pacific Advisors (Trades, Portfolio) with 0.42% and Bill Nygren (Trades, Portfolio) with 0.36%.
The GlaxoSmithKline PLC (GSK, Financial) holding was curbed by 3.22%, impacting the portfolio by -0.22%.
The drug manufacturer has a market cap of $87.76 billion and an enterprise value of $111.72 billion.
GuruFocus gives the company a profitability and growth rating of 6 out of 10. While the ROE of 229.78% is outperforming the sector, the ROA of 3.97% is underperforming 57% of companies in the Global Drug Manufacturers - Major industry. Financial strength has a rating of 4 out of 10. The cash-debt ratio of 0.25 is below the industry median of 2.89.
The company's largest shareholder among the gurus is Ken Fisher (Trades, Portfolio) with 0.52% of outstanding shares, followed by Simons with 0.38%, Hotchkis & Wiley with 0.32%, Charles Brandes (Trades, Portfolio) with 0.14% and NWQ Managers (Trades, Portfolio) with 0.1%.
The MBIA Inc. (MBI, Financial) position was reduced by 3.28%. The trade had an impact of -0.21% on the portfolio.
The insurance company has a market cap of $815.91 million and an enterprise value of $3.14 billion.
GuruFocus gives the company a profitability and growth rating of 4 out of 10. The ROE of -66.65% and ROA of -17.21% are underperforming 99% of the companies in the Global Insurance - Property and Casualty industry. Financial strength has a rating of 3 out of 10. The cash-debt ratio of 0.05 is below the industry median of 3.15.
With 3.45% of outstanding shares, Kahn Brothers is the company's largest guru shareholder, followed by Royce with 3.07%, Steven Cohen (Trades, Portfolio) with 1.14% and Francis Chou (Trades, Portfolio) with 0.86%.
Disclosure: I do not own any stocks mentioned in this article.
